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Axis determination in Xenopus involves biochemical interactions
of axin, glycogen synthase kinase 3 and b-catenin
Keiji Itoh, Valery E. Krupnik and Sergei Y. Sokol
Signaling by the Wnt family of extracellular proteins is
critical in a variety of developmental processes in
which cell and tissue polarity are established [1–5].
Wnt signal transduction has been studied mostly by
the genetic approach in Drosophila and
Caenorhabditis elegans [1,2,5], but the biochemical
mechanisms involved remain to be elucidated. The
Wnt pathway also operates during axis determination
in vertebrates [3,5]. Frizzled receptors transduce a
signal to Dishevelled, leading to inactivation of
glycogen synthase kinase 3 (GSK3) and regulation of
gene expression by the complex of b-catenin with
LEF/TCF (lymphocyte enhancer factor/T-cell factor)
transcription factors [3,5]. Axin is a negative regulator
of Wnt signaling and dorsal axial development in
vertebrates [6]. Here, we demonstrate that axin is
associated with GSK3 in the Xenopus embryo and we
localize the GSK3-binding domain to a short region of
axin. Binding of GSK3 correlates with the ability of
axin to inhibit axial development and with the axis-
inducing activity of its dominant-negative form (DRGS).
We also find that wild-type axin, but not DRGS, forms a
complex with b-catenin. Thus, axin may act as a
docking station mediating negative regulation of 
b-catenin by GSK3 during dorsoventral axis
determination in vertebrate embryos. 
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Results and discussion
To gain an insight into the mode of action of axin, we tested
its ability to interact with the known components of the
Wnt signal transduction pathway. Xenopus early embryos
were microinjected with axin mRNA, and Myc-tagged axin
was precipitated from the embryonic lysates using tag-spe-
cific (9E10) monoclonal antibodies. Western blot analysis of
the immunoprecipitates using GSK3-specific antibodies
revealed the presence of GSK3 in the same protein complex
as axin (Figure 1b, lanes 6,8). To define which region of
axin is involved in GSK3 binding, we carried out
structure–function analyses. Axin contains two regions with
similarity to other proteins: the RGS (regulator of G-protein
Figure 1
(a) Axin constructs used in this study. (b) Defining the GSK3-binding
domain in axin. Myc-tagged axin constructs were overexpressed in
Xenopus embryos by microinjection of the corresponding mRNAs into
all blastomeres at the four-cell stage. Embryo lysates were
immunoprecipitated (IP) at the early gastrula stage (stage 10+) with
9E10 antibodies followed by western analysis with anti-GSK3β
(α-GSK3β) monoclonal antibodies. The arrow indicates a position
corresponding to GSK3. (c) Expression of axin derivatives detected
with 9E10 antibodies. The same membrane was used in (b) and (c).
The asterisk in (b,c) denotes the immunoglobulin heavy chain
recognized by the secondary antibodies; the double asterisk in 
(c) marks a nonspecific protein band.
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signaling) domain and the Dishevelled homology (DIX)
domain [5,6]. Different deletion constructs of axin were
overexpressed in early embryos (Figure 1a,c) and their
ability to associate with GSK3 was determined (Figure 1b).
GSK3 was efficiently bound to C1, C2, N1, ∆RGS, ∆RGS-
N1, ∆RGS-C2 and ∆RGS-NC1 axin constructs (Figure 1b),
but not to ∆RGS-C3 (data not shown), C3, C4, C5 and
∆RGS-C4 constructs (Figure 1b). All derivatives of axin
were expressed at high levels and efficiently precipitated by
the 9E10 antibodies (Figure 1c). These observations indi-
cate that the region of axin containing amino acids 527–724
is indispensable for GSK3 binding. 
Although these experiments establish the biochemical
association of axin and GSK3, they do not demonstrate
whether this association is relevant to the function of axin
during vertebrate axis determination. In amphibians, the
dorsoventral axis is established with the formation of a
dorsal inducing center or Spemann organizer [7]. Overex-
pression of axin in dorsovegetal blastomeres, which are
known to give rise to the organizer, leads to inhibition of
dorsal development [6]. We wanted to assess whether this
ventralizing activity of axin is retained in those axin deriv-
atives that no longer interact with GSK3. To that end,
RNAs encoding different forms of axin (Figure 1a) were
injected into both dorsal blastomeres of the four-cell
embryos, and their axial development was assessed mor-
phologically and scored using the dorso-anterior index [8].
Whereas the wild-type, C1, C2 and N1 forms of axin had a
pronounced ventralizing activity, C3, C4 and C5 con-
structs failed to significantly alter axial development
(Figure 2a,b,e and data not shown). Embryos injected
with C3 and C4 constructs occasionally had anterior ecto-
derm deficiencies as well as defects in morphogenetic
movements, which resulted in the average dorso-anterior
index being lower than for uninjected embryos
(Figure 2e). These experiments show that the same region
that is necessary for GSK3 binding (amino acids 527–724)
is also required for the ability of axin to cause ventraliza-
tion. Thus, the biochemical association of axin and GSK3
correlates tightly with the functional activity of axin.
Although the formation of axin–GSK3 complex appears to
be necessary for the ability of axin to inhibit dorsal devel-
opment, it is clearly not sufficient, as this inhibition
requires the presence of the intact RGS domain. A form of
axin (∆RGS) lacking this domain has been shown to have
an effect opposite to that of the wild-type axin [6].
Microinjection of ∆RGS mRNA into ventral blastomeres
leads to induction of a complete secondary axis, support-
ing the view that the endogenous axin functions to repress
dorsal development. We tested whether GSK3 binding
correlates with the ability of different ∆RGS constructs
(Figure 1a) to elicit secondary axis formation in ventral
blastomeres (Figure 2c,d,f). ∆RGS-C2, ∆RGS-N1 and
∆RGS-NC1 retained the ability to induce a secondary
axis, but ∆RGS-C3 and ∆RGS-C4 lost it. Thus, the same
GSK3-binding region is required for the axis-inducing
activity of ∆RGS. The simplest explanation for these
observations is that ∆RGS sequesters GSK3, a negative
regulator of axial development [9–11], and thereby leads
to induction of a secondary axis. As ∆RGS can still bind
GSK3 (Figure 1b), the RGS domain is required for a func-
tion of axin that is independent of GSK3 binding. 
Our experiments show that the association between axin
and GSK3 correlates tightly with the ability of axin to
inhibit dorsal development and we have defined a con-
served domain that is essential for axin’s functional activ-
ity. To test the possibility that axin may regulate the
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Figure 2
Association of GSK3 with axin correlates with the effects of axin and
its dominant-negative form on axis determination in Xenopus embryos.
Overexpression of (a) C2 mRNA, but not (b) C3 mRNA, in both
dorsovegetal blastomeres of four-cell embryos leads to inhibition of
dorsal axial development. Overexpression of (c) ∆RGS-C2 mRNA, but
not (d) ∆RGS-C3 mRNA, in a ventral blastomere induces a complete
secondary axis. Embryos shown in (d) are indistinguishable from
uninjected control siblings. (e) Inhibition of dorsal development by
different axin constructs. DAI, dorso-anterior index. (f) Axis-inducing
activity of different ∆RGS constructs. Filled bars represent embryos
with complete axes, including eyes and cement glands; open bars
represent embryos with partial neural tubes and hindbrain, but lacking
fore/midbrain structures.
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kinase activity of GSK3, we studied GSK3-dependent
phosphorylation of myelin basic protein (MBP) in
immune complexes (Figure 3a,b). Whereas the immuno-
precipitated axin complex contained a kinase activity, no
kinase activity was associated with a control C3 construct
that does not bind GSK3, suggesting that MBP phospho-
rylation is dependent on GSK3. When compared with
axin-associated GSK3, ∆RGS-associated GSK3 appeared
to have somewhat lower kinase activity, although this dif-
ference may not be significant (Figure 3a,b). In agreement
with previously observed negative regulation of GSK3 by
Wnt signaling [5,12], injection of Xwnt8 RNA resulted in
a decrease in the total GSK3 activity and in axin-associ-
ated kinase activity (Figure 3a,b). In contrast, overexpres-
sion of Xwnt8 (Figure 3a) or Xdsh (data not shown) did
not change the amount of GSK3 complexed with Myc-
tagged axin. These observations are consistent with a
model in which Wnt signaling leads to down-regulation of
axin-associated GSK3 activity.
To evaluate the possibility that axin interacts with other
components of the Wnt pathway in addition to GSK3 and
makes them available for regulation by the kinase, we
assessed binding of axin to β-catenin, a potential substrate
of GSK3 [13]. Embryos were injected with mRNAs
encoding different axin constructs and lysed at the early
gastrula stage for protein analysis. Immunoprecipitation
with Myc-specific 9E10 antibodies followed by western
blot analysis with anti-β-catenin antibodies has shown that
β-catenin is also associated with axin (Figure 3c). We
observed the binding of β-catenin to the wild-type axin,
C1 and N1, but not to C3, C5 and ∆RGS axin derivatives
(Figure 3c). As none of the ∆RGS constructs was associ-
ated with β-catenin, the RGS domain may be an important
regulator of β-catenin binding. Consistent with the ability
of axin to interact with β-catenin, axin caused a dose-
dependent suppression of the axis-inducing activity of β-
catenin in ventral blastomeres (data not shown). 
This study supports and extends the model in which Wnt
signaling leads to inhibition of GSK3 activity, thus allow-
ing β-catenin to translocate into the nucleus and associate
with LEF/TCF factors to regulate target gene expression
[5]. Our results suggest that axin may negatively regulate
the Wnt pathway by bridging GSK3 with β-catenin and
thus promoting β-catenin inactivation. Overall, this role
for axin is similar to the proposed role for APC [14,15]. At
present, the involvement of APC in the Wnt pathway
remains unclear because, in contrast to axin, the Xenopus
homologue of APC stimulates, rather than inhibits, dorsal
development [16]. We also provide an explanation for the
dominant-negative effect of the ∆RGS construct. ∆RGS is
capable of binding GSK3, but is unable to interact with β-
catenin. Thus, ∆RGS may prevent GSK3 from phosphory-
lating β-catenin, thereby exerting a positive effect on Wnt
signaling and dorsal development. 
Our results, as well as those of an independent study [17],
reveal a biochemical link between axin and the Wnt
pathway. As RGS domains are known to regulate G-
protein-coupled signaling by stimulating hydrolysis of the
GTP bound to activated Gα subunits [18], axin may
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Figure 3
(a) Axin-associated kinase activity is down-regulated by Xwnt8.
Embryos were injected with different RNAs as indicated. Embryonic
lysates were prepared at stage 10+ for precipitation with specific
antibodies. An immune complex kinase assay was carried out with
myelin basic protein (MBP) as a substrate. Expression levels of axin,
∆RGS, C3 and GSK3 (arrowhead) were analysed with specific
antibodies. (b) Comparative analysis of GSK3 activity by immune
complex kinase assay. Relative kinase activity was calculated as a ratio
of MBP phosphorylation to the amount of GSK3β. Data were
normalized by the median between the highest value and background
and are shown as the mean ± standard error from three experiments.
C, uninjected control embryos. 9E10 antibodies (left panel) or anti-
GSK3β antibodies (right panel) were used for immunoprecipitations.
(c) Association of β-catenin with axin. Embryos were injected with
RNAs encoding different forms of axin as indicated. Axin complexes
were precipitated from cell lysates with 9E10 antibodies and the
presence of β-catenin (arrowhead) was evaluated on western blots
with specific antiserum (α-βcat, bottom panel). The lower band
corresponds to an unknown cross-reacting protein. Expression of axin
constructs was assessed with 9E10 antibodies (top panel). 
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bridge G proteins and Wnt signaling. Moreover, the con-
served DEP domain of Dishevelled [19] was proposed to
be involved in the control of G-protein signaling.
Although the activity of some Wnts, such as Xwnt5a, is
known to be sensitive to G-protein inhibitors [20], addi-
tional experiments are necessary to elucidate the role for
G proteins in dorsal development.
Materials and methods 
Embryos, DNA constructs and RNA microinjections
Construction of the different forms of axin cDNA (Figure 1a) was based
on the available restriction enzyme sites SacI, StuI, XbaI, SpeI, PstI,
BglII and EcoRI. Capped synthetic RNAs were generated by in vitro
transcription with SP6 RNA polymerase [21]. Eggs and embryos were
obtained from Xenopus females and cultured in 0.1 × MMR (Marc’s
Modified Ringer) as described [22]. Embryonic stages were deter-
mined according to Nieuwkoop and Faber [23]. For microinjection,
embryos were transferred to 3% Ficoll in 0.5 × MMR and injected at
the four-cell stage with 10 nl of a solution containing 0.5–1 ng RNA
from axin constructs or 5 pg Xwnt8 RNA. Injections were carried out in
one ventral blastomere for secondary axis induction, two dorsal blas-
tomeres for assaying the ventralizing activity of axin, and all four blas-
tomeres for protein analysis. Embryonic phenotypes were scored
morphologically at the equivalent of stage 35. The results were com-
bined for at least three independent experiments.
Immunoprecipitation, western analysis and kinase assays
Injected embryos were lysed in 500 µl lysis buffer (0.5% NP40, 10 mM
Tris-HCl at pH 7.5, 50 mM NaCl, 1 mM EDTA, 0.6 mM PMSF) when
sibling embryos had developed to the early gastrula stages (stage
10+–10.5). Lysates were cleared by centrifugation at 10,000 g for
10 min. Anti-Myc monoclonal antibody (20 µl 9E10 hybridoma super-
natant) or 1 µg monoclonal anti-GSKβ antibodies (Transduction Labs)
was incubated with the lysates for 2 h at room temperature. Protein A
or Protein G–agarose (25 µl of 50% suspension) was added and incu-
bated for an additional 40 min. The immunoprecipitates were washed
three times with the lysis buffer and resuspended in a sample buffer.
After separation in a 10% SDS–polyacrylamide gel, samples were
electroblotted onto PVDF membrane (Millipore) at 100 V for 2 h. The
membrane was blocked with 5% skim milk for 1 h and incubated
overnight at 4°C with the 9E10, anti-GSK3β monoclonal or anti-β-
catenin polyclonal antibodies. After washing three times with PBS plus
0.1% Tween-20, the membrane was incubated with horseradish perox-
idase-conjugated secondary antibodies (Jackson) for 1 h. Peroxidase
activity was visualized by enhanced chemiluminescence as described
[24]. The membranes were stripped and re-probed after incubating for
15 min in 7 M guanidine-HCl, 50 mM Tris-HCl (pH 8.0), 20 mM DTT,
2 mM EDTA. For GSK3 activity determination, immunoprecipitates
were washed three times with the lysis buffer and twice with 30 mM
Tris-HCl, pH 7.5, 10 mM MgCl2. Immune complex kinase assays were
carried out using [γ32P]ATP and MBP as described [25]. Phosphoryla-
tion of MBP was quantitated using Instant Image PhosphoImager. Rela-
tive kinase activity was calculated as a ratio of MBP phosphorylation
(cpm × 100) to the amount of GSK3 measured by optical density. Each
experiment was repeated at least three times. 
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